174 related articles for article (PubMed ID: 27468213)
1. Glucose deprivation induces chemoresistance in colorectal cancer cells by increasing ATF4 expression.
Hu YL; Yin Y; Liu HY; Feng YY; Bian ZH; Zhou LY; Zhang JW; Fei BJ; Wang YG; Huang ZH
World J Gastroenterol; 2016 Jul; 22(27):6235-45. PubMed ID: 27468213
[TBL] [Abstract][Full Text] [Related]
2. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
3. ATF4-mediated microRNA-145/HDAC4/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy.
Zhao L; Chen H; Zhang Q; Ma J; Hu H; Xu L
Cancer Chemother Pharmacol; 2022 May; 89(5):595-607. PubMed ID: 35312836
[TBL] [Abstract][Full Text] [Related]
4. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin.
Zhang YJ; Li AJ; Han Y; Yin L; Lin MB
World J Gastroenterol; 2014 Jul; 20(25):8229-36. PubMed ID: 25009397
[TBL] [Abstract][Full Text] [Related]
6. ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma.
Luo J; Xia Y; Yin Y; Luo J; Liu M; Zhang H; Zhang C; Zhao Y; Yang L; Kong L
Theranostics; 2019; 9(21):6334-6353. PubMed ID: 31534554
[No Abstract] [Full Text] [Related]
7. Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer.
Wang X; Zuo D; Chen Y; Li W; Liu R; He Y; Ren L; Zhou L; Deng T; Wang X; Ying G; Ba Y
Br J Cancer; 2014 Nov; 111(10):1965-76. PubMed ID: 25321193
[TBL] [Abstract][Full Text] [Related]
8. Stanniocalcin 2 induces oxaliplatin resistance in colorectal cancer cells by upregulating P-glycoprotein.
Yuan Q; Zhan L; Zhang LL; Wang Q; Liu J; Jiang ZY; Hu XM; Yuan XC
Can J Physiol Pharmacol; 2016 Sep; 94(9):929-35. PubMed ID: 27245421
[TBL] [Abstract][Full Text] [Related]
9. MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis.
Li L; Shang J; Zhang Y; Liu S; Peng Y; Zhou Z; Pan H; Wang X; Chen L; Zhao Q
Oncol Rep; 2017 Sep; 38(3):1383-1392. PubMed ID: 28731151
[TBL] [Abstract][Full Text] [Related]
10. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.
Wang L; Jiang CF; Li DM; Ge X; Shi ZM; Li CY; Liu X; Yin Y; Zhen L; Liu LZ; Jiang BH
Oncotarget; 2016 Jan; 7(3):2660-71. PubMed ID: 26673620
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.
Wang D; Yang L; Yu W; Wu Q; Lian J; Li F; Liu S; Li A; He Z; Liu J; Sun Z; Yuan W; Zhang Y
J Immunother Cancer; 2019 Aug; 7(1):215. PubMed ID: 31395078
[TBL] [Abstract][Full Text] [Related]
13. N-acetyl cysteine and penicillamine induce apoptosis via the ER stress response-signaling pathway.
Guan D; Xu Y; Yang M; Wang H; Wang X; Shen Z
Mol Carcinog; 2010 Jan; 49(1):68-74. PubMed ID: 19722195
[TBL] [Abstract][Full Text] [Related]
14. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z
Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050
[TBL] [Abstract][Full Text] [Related]
15. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
16. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
[TBL] [Abstract][Full Text] [Related]
17. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment.
Yang HZ; Ma Y; Zhou Y; Xu LM; Chen XJ; Ding WB; Zou HB
Cancer Lett; 2015 May; 361(1):128-36. PubMed ID: 25749420
[TBL] [Abstract][Full Text] [Related]
18. Activation of LXRβ inhibits proliferation, promotes apoptosis, and increases chemosensitivity of gastric cancer cells by upregulating the expression of ATF4.
Liu J; Qi YB
J Cell Biochem; 2019 Sep; 120(9):14336-14347. PubMed ID: 31210377
[TBL] [Abstract][Full Text] [Related]
19. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
Fang Z; Gong C; Yu S; Zhou W; Hassan W; Li H; Wang X; Hu Y; Gu K; Chen X; Hong B; Bao Y; Chen X; Zhang X; Liu H
Cancer Lett; 2018 Feb; 415():58-72. PubMed ID: 29203250
[TBL] [Abstract][Full Text] [Related]
20. Activating transcription factor 4 mediates a multidrug resistance phenotype of esophageal squamous cell carcinoma cells through transactivation of STAT3 expression.
Zhu H; Chen X; Chen B; Chen B; Fan J; Song W; Xie Z; Jiang D; Li Q; Zhou M; Sun D; Zhao Y
Cancer Lett; 2014 Nov; 354(1):142-52. PubMed ID: 25130172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
